H-Source Blog

linkedin-In-Stream_Wide___Epi Pen- Blog Page

Win for Consumers: Increase in Generic Pharmaceuticals

by H-Source on 10/10/2018

Having troubles finding certain medications? The FDA has implemented the Drug Competition Action Plan. This plan means that certain brand name medications with no listed patents or exclusivities, are now encouraged to develop generic alternatives. The FDA will also expedite the review of any generic drug application to ensure that less expensive medications are available as soon as possible.

This is not only a good thing for consumers, but for providers and facilities alike. Prescription medications cost hospitals and facilities more and more each day. Having the ability to search and purchase generic alternatives, allows for them to pass the savings along to the consumer.

Recently, the FDA also approved the first generic version of the EpiPen. Now that there are more options for generics and companies to supply it, consumers and hospitals will be able to gain access to this life saving medication at a lower cost.